BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15013685)

  • 1. The androgen receptor: a potential target for therapy of prostate cancer.
    Santos AF; Huang H; Tindall DJ
    Steroids; 2004 Feb; 69(2):79-85. PubMed ID: 15013685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM; Tindall DJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of androgen-independent prostate cancer.
    Feldman BJ; Feldman D
    Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction in prostate cancer progression.
    Gioeli D
    Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
    Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
    Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor gene and its influence on the development and progression of prostate cancer.
    Montgomery JS; Price DK; Figg WD
    J Pathol; 2001 Sep; 195(2):138-46. PubMed ID: 11592091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
    Schröder FH
    Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor: role and novel therapeutic prospects in prostate cancer.
    Taplin ME
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1495-508. PubMed ID: 18759700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
    J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog signalling in androgen independent prostate cancer.
    Shaw G; Price AM; Ktori E; Bisson I; Purkis PE; McFaul S; Oliver RT; Prowse DM
    Eur Urol; 2008 Dec; 54(6):1333-43. PubMed ID: 18262716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.
    Berger R; Febbo PG; Majumder PK; Zhao JJ; Mukherjee S; Signoretti S; Campbell KT; Sellers WR; Roberts TM; Loda M; Golub TR; Hahn WC
    Cancer Res; 2004 Dec; 64(24):8867-75. PubMed ID: 15604246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
    Taplin ME
    Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.
    Burnstein KL
    J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine control of prostate cancer.
    Wilding G
    Cancer Surv; 1995; 23():43-62. PubMed ID: 7621473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
    Debes JD; Comuzzi B; Schmidt LJ; Dehm SM; Culig Z; Tindall DJ
    Cancer Res; 2005 Jul; 65(13):5965-73. PubMed ID: 15994976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
    Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
    Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K-Akt signaling is involved in the regulation of p21(WAF/CIP) expression and androgen-independent growth in prostate cancer cells.
    Lu S; Ren C; Liu Y; Epner DE
    Int J Oncol; 2006 Jan; 28(1):245-51. PubMed ID: 16328002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.